Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • Texas releases informal draft rule to close compounded loophole

    by
    • Optum Workers' Comp
    | Jun 20, 2017
    Tag Icon
    Workers' Compensation, Formularies, Compounded Medications
    The Texas Division of Workers’ Compensation (DWC) recently released an informal draft rule amending the closed formulary definition in Rule 134.500. The amended definition would exclude any compounded medication from the closed formulary. Medications excluded from the Texas Closed Formulary can only be prescribed following a prior authorization process including documentation of medical necessity. Previously, only compounded medications with an “N” ingredient, as identified in the Official Disability Guidelines (ODG) Appendix A, were excluded from the closed formulary.


  • Louisiana latest to adopt initial limits for Opioid Analgesics

    by
    • Optum Workers' Comp
    | Jun 20, 2017
    Tag Icon
    Opioids
    Louisiana Governor John Bel Edwards recently signed into law HB 192, sponsored by Representative Helena Moreno – D (Orleans Parish). HB 192 has several components that are similar to the opioid limit laws that have passed in other states. The bill amends the Louisiana Public Health and Safety law R.S. 40:978 by adding section (G) limiting the initial prescription for an opioid analgesic for treating acute pain to a seven-day supply. This section does give some flexibility to the treating physician to prescribe more than a seven-day supply if, “in the professional medical judgment of a medical practitioner, more than a seven-day supply of an opioid is required to treat the adult or minor patient’s acute medical condition...” This section would also require the practitioner to document, in the patient’s medical record, the condition triggering the need for an opioid analgesic beyond the seven-day prescribing limit.


  • Medication recall for one lot of Eliquis® (apixaban)

    by
    • Optum Workers' Comp
    | Jun 15, 2017
    Tag Icon
    Medication Recall
    Bristol-Myers Squibb Company announced a consumer-level recall on one lot of Eliquis® (apixaban) 5 mg tablets were mislabeled due to a complaint from a customer who found Eliquis 2.5 mg tablets in their bottle that should have contained 5 mg tablets.


  • Generic Roxicodone® tablets approved by FDA

    by
    • Optum Workers' Comp
    | Jun 14, 2017
    Tag Icon
    Opioids, FDA
    The U.S. Food and Drug Administration (FDA) has approved a generic version of Mallinckrodt Inc.’s Roxicodone® tablets. Oxycodone hydrochloride is an immediate-release opioid analgesic indicated to manage pain severe enough to require an opioid analgesic and for which alternative treatment options are inadequate.






Subscribe

Stay informed by signing up to receive newsletters, alerts, insights and videos.
You can customize your content preferences after you subscribe.